When does menopause typically start. What are the common symptoms of perimenopause. How long does the transition to menopause usually last. What treatments are available for managing menopausal symptoms. How does early menopause differ from typical menopause. What lifestyle changes can help ease menopausal symptoms. How does menopause affect overall health and well-being.

Understanding the Menopausal Transition: Ages and Stages

Menopause is a natural biological process that marks the end of a person’s reproductive years. While it’s commonly associated with individuals in their 50s, the menopausal transition can actually begin much earlier and last for several years. To better understand this complex journey, let’s explore the different stages and age ranges associated with menopause.

What is the average age for menopause?

On average, most people assigned female at birth (AFAB) begin menopause between the ages of 45 and 55. However, it’s important to note that the onset of menopause can vary widely among individuals due to factors such as genetics, overall health, and lifestyle choices.

How long does the transition to menopause typically last?

The transition stage, known as perimenopause, can last approximately 7 years on average. However, for some individuals, this phase may extend up to 14 years. During this time, hormone levels begin to fluctuate, leading to various symptoms and changes in menstrual patterns.

Early Menopause: Causes, Symptoms, and Implications

While menopause typically occurs in the late 40s to early 50s, some individuals may experience early menopause, which can have significant implications for their health and family planning goals.

What is considered early menopause?

Early menopause is defined as the onset of menopausal symptoms between the ages of 40 and 45. Approximately 5% of women experience early menopause. Even more rare is premature menopause, which affects about 1% of women and occurs before the age of 40.

What are the potential causes of early menopause?

• Natural genetic predisposition
• Surgical removal of ovaries
• Cancer treatments (radiation or chemotherapy)
• Autoimmune diseases
• Smoking

A 2018 review of studies highlighted that smoking can significantly increase the likelihood of experiencing early menopause onset. This underscores the importance of lifestyle factors in influencing reproductive health.

What are the signs of early menopause?

Individuals experiencing early menopause may notice the following symptoms:

• Missing more than three periods in a row
• Changes in menstrual flow (heavier or lighter than usual)
• Sleep disturbances
• Weight gain
• Hot flashes
• Vaginal dryness

It’s crucial to consult with a healthcare provider if you experience these symptoms, as they can also be indicative of other medical conditions or pregnancy.

Perimenopause: The Transitional Phase

Perimenopause is the stage leading up to menopause, typically beginning in the late 40s. This phase is characterized by hormonal fluctuations and the gradual decline of estrogen and progesterone production.

How long does perimenopause typically last?

The duration of perimenopause can vary significantly among individuals, ranging from 7 to 14 years. During this time, menstrual cycles may become irregular, and various symptoms may emerge.

What are the common symptoms of perimenopause?

Perimenopausal symptoms are primarily caused by fluctuating estrogen levels and may include:

• Hot flashes and night sweats
• Mood swings
• Vaginal dryness
• Sleep disturbances
• Changes in libido
• Difficulty concentrating
• Hair loss
• Heart palpitations
• Urinary issues

It’s important to note that while fertility declines during perimenopause, pregnancy is still possible. Individuals who wish to avoid pregnancy should continue using contraception during this phase.

Menopause: Symptoms and Management Strategies

Menopause is officially reached when an individual has gone 12 consecutive months without a menstrual period. This typically occurs in the early to mid-50s for most AFAB individuals.

What are the most common menopausal symptoms?

Menopausal symptoms can vary in intensity and duration but often include:

• Hot flashes and night sweats
• Vaginal dryness and discomfort
• Sleep disturbances
• Mood changes and irritability
• Urinary issues
• Changes in skin and hair texture
• Weight gain and slowed metabolism

How can menopausal symptoms be managed effectively?

There are several approaches to managing menopausal symptoms:

1. Hormone Therapy (HT): This involves supplementing the body with estrogen and, in some cases, progesterone to alleviate symptoms like hot flashes and vaginal dryness.
2. Non-hormonal medications: Certain antidepressants, anti-seizure drugs, and blood pressure medications may help manage specific symptoms.
3. Lifestyle modifications: Regular exercise, stress reduction techniques, and dietary changes can help alleviate some menopausal symptoms.
4. Natural remedies: Some individuals find relief through herbal supplements or acupuncture, although scientific evidence for their efficacy is mixed.

It’s essential to consult with a healthcare provider to determine the most appropriate management strategy based on individual health history and symptom severity.

Post-Menopause: Long-Term Health Considerations

The post-menopausal phase begins after an individual has gone 12 consecutive months without a menstrual period. While some menopausal symptoms may persist, this stage also brings new health considerations.

What health risks increase after menopause?

Post-menopausal individuals may face an increased risk of certain health conditions, including:

• Osteoporosis
• Cardiovascular disease
• Urinary incontinence
• Sexual dysfunction
• Weight gain and metabolic changes

How can post-menopausal health be maintained?

To promote overall health and well-being during the post-menopausal years, consider the following strategies:

• Regular health screenings, including bone density tests and cardiovascular assessments
• Maintaining a balanced diet rich in calcium and vitamin D
• Engaging in weight-bearing exercises to support bone health
• Practicing pelvic floor exercises to improve urinary control
• Staying sexually active to maintain vaginal health
• Managing stress through relaxation techniques or mindfulness practices

Hormonal Changes and Their Impact on Overall Health

The hormonal fluctuations associated with menopause can have far-reaching effects on an individual’s physical and emotional well-being. Understanding these changes is crucial for managing symptoms and maintaining optimal health throughout the menopausal transition and beyond.

How do hormonal changes affect bone health?

The decline in estrogen levels during menopause can lead to accelerated bone loss, increasing the risk of osteoporosis. This condition makes bones more fragile and susceptible to fractures. To mitigate this risk, it’s important to focus on bone-strengthening activities and ensure adequate calcium and vitamin D intake.

What impact does menopause have on cardiovascular health?

Estrogen plays a protective role in cardiovascular health. As estrogen levels decrease during menopause, the risk of heart disease and stroke increases. This makes it essential for post-menopausal individuals to pay close attention to heart health through regular exercise, a balanced diet, and management of other risk factors such as high blood pressure and cholesterol levels.

How does menopause affect mental health and cognitive function?

Hormonal changes during menopause can influence mood and cognitive function. Some individuals may experience increased anxiety, depression, or difficulty concentrating. While these changes are often temporary, they can significantly impact quality of life. Engaging in regular mental exercises, maintaining social connections, and seeking professional support when needed can help manage these challenges.

Lifestyle Modifications to Support Menopausal Health

Adopting healthy lifestyle habits can significantly improve the menopausal experience and promote overall well-being. Here are some key areas to focus on:

What dietary changes can help manage menopausal symptoms?

A balanced diet rich in whole foods can help alleviate some menopausal symptoms and support overall health. Consider incorporating the following:

• Phytoestrogen-rich foods like soy, flaxseeds, and legumes
• Calcium and vitamin D-rich foods for bone health
• Omega-3 fatty acids for heart and brain health
• Plenty of fruits and vegetables for antioxidant support
• Adequate hydration to help manage hot flashes

How can exercise benefit menopausal individuals?

Regular physical activity offers numerous benefits during menopause, including:

• Improved mood and reduced anxiety
• Better sleep quality
• Maintenance of healthy body weight
• Increased bone density through weight-bearing exercises
• Enhanced cardiovascular health

Aim for a combination of aerobic exercise, strength training, and flexibility work for optimal results.

What stress management techniques are effective during menopause?

Stress can exacerbate menopausal symptoms, making stress management an essential component of overall well-being. Consider incorporating the following techniques:

• Mindfulness meditation
• Deep breathing exercises
• Yoga or tai chi
• Regular relaxation practices
• Engaging in hobbies or creative pursuits

Navigating Relationships and Intimacy During Menopause

Menopause can bring changes to relationships and sexual health. Open communication and a proactive approach to intimacy can help maintain fulfilling connections during this transitional period.

How does menopause affect sexual health?

Hormonal changes during menopause can lead to various sexual health issues, including:

• Decreased libido
• Vaginal dryness and discomfort during intercourse
• Changes in sexual response and satisfaction

These challenges can be addressed through open communication with partners, use of lubricants, and consultation with healthcare providers for appropriate treatments if needed.

What strategies can help maintain healthy relationships during menopause?

To nurture relationships during the menopausal transition, consider the following approaches:

• Maintain open and honest communication with partners about physical and emotional changes
• Explore new forms of intimacy and connection
• Seek couples counseling if needed to navigate challenges together
• Prioritize self-care and individual well-being to bring your best self to the relationship
• Educate partners about menopausal changes to foster understanding and support

By addressing relationship and intimacy concerns proactively, individuals can maintain strong, supportive connections throughout the menopausal journey.

Symptoms of Menopause at Every Age: 40 to 65

Menopause typically begins between ages 40-65 and can be affected by genetics, health, and lifestyle. Symptoms may include missed periods, hot flashes, and weight gain.

As people age, hormone levels start to change. For instance, as individuals assigned female at birth (AFAB) become older adults, they start transitioning into menopause, which can include hot flashes, mood swings, and other symptoms.

Even though people experience menopause differently, certain trends in the age of onset and symptoms can provide some guidance on what you can expect as you get older.

As you get older, your ovaries produce less of the hormones estrogen and progesterone. Without these hormones, periods become erratic for a time, and then eventually stop.

Once you’ve been without a period for 12 months, you’re most likely officially in menopause. On average, most vagina owners start menopause between the ages of 45 and 55.

The physical changes that usher in menopause can begin as early as age 40 or may not start until your late 50s.

The transition stage, or perimenopause, can last about 7 years, but for some, it can last as long as 14 years. During this phase, hormone levels begin to drop.

Smoking, along with age of onset, race, and ethnicity, can all affect how long perimenopause symptoms last.

Similarly, certain factors, such as smoking, can affect when menopause starts. A 2018 review of studies showed that smoking can greatly increase the chance of early menopause onset.

Here’s a look at menopause through the ages, and what types of symptoms to possibly expect as you reach each milestone.

It’s important to keep in mind that early menopause, perimenopause, and menopause symptoms are not linear or fully defined by age. You may find yourself experiencing some when you’re younger and others as menopause is underway.

No matter how it progresses, it’s important to talk with your doctor, so they can help you to manage your symptoms.

A couple of missed periods when you’re 40 might make you think you’re pregnant, but it’s also possible to begin menopause around this age.

About 5 percent of women go into early menopause, experiencing symptoms between the ages of 40 and 45. One percent of women go into premature menopause before age 40.

Early menopause can occur naturally. Or, it may be triggered by surgery to remove your ovaries, cancer treatments like radiation or chemotherapy, or autoimmune diseases.

Signs you’re in early menopause include:

• missing more than three periods in a row
• heavier or lighter than usual periods
• trouble sleeping
• weight gain
• hot flashes
• vaginal dryness

Because these can also be symptoms of pregnancy or other medical conditions, you should consider seeing your doctor for evaluation.

If you’re in early menopause, hormone therapy can help alleviate hot flashes, vaginal dryness, and other menopausal symptoms.

Going into menopause early could prevent you from starting a family if you’ve been waiting. You may want to consider options, like freezing your remaining eggs or using donor eggs to conceive.

Many AFAB folks enter the perimenopausal phase in their late 40s. Perimenopause means “around menopause.” At this stage, your estrogen and progesterone production slows, and you begin to make the transition into menopause.

Perimenopause can last 7 to 14 years. You’ll likely still get a period during this time, but your menstrual cycles will become more erratic.

During the last year or two of perimenopause, you may skip periods. The periods you do get could be heavier or lighter than usual.

Symptoms of perimenopause are due to rising and falling estrogen levels in your body. You may experience:

• hot flashes
• mood swings
• night sweats
• vaginal dryness
• difficulty sleeping
• changes in sex drive
• trouble concentrating
• hair loss
• fast heart rate
• urinary problems

It’s harder to get pregnant during perimenopause, but it’s not impossible. If you don’t want to conceive, continue to use contraception during this time.

During your early 50s, you may be in menopause, or you may be making the final transition into this phase. At this point, your ovaries are no longer releasing eggs or making much estrogen.

The change from perimenopause to menopause can take several years. Symptoms, like hot flashes, vaginal dryness, and sleeping difficulties, are common during this time.

If these symptoms are imposing on your daily life and activities, talk with your doctor about hormone therapy and other treatments that can help relieve them.

By age 55, most AFAB individuals have gone through menopause. Once a full year has passed since your last period, you’re officially in the postmenopausal phase.

You may still have some of the same symptoms you experienced during perimenopause and menopause, including:

• hot flashes
• night sweats
• mood changes
• vaginal dryness
• difficulty sleeping
• irritability and other mood changes
• urinary problems

In the postmenopausal stage, your risk for heart disease can increase. Talk with your doctor about making lifestyle changes to protect yourself against heart disease and other age-related diseases.

A small percentage of AFAB folks are late going into menopause. This isn’t necessarily a bad thing.

Studies have linked late menopause to a lower risk of:

• heart disease
• heart attack
• stroke
• osteoporosis

It’s also linked to a longer life expectancy. Researchers believe that prolonged exposure to estrogen protects the heart and bones.

If you’ve already been through menopause, it doesn’t always mean you’re done with all the symptoms. An estimated 40 percent of women ages 60 to 65 still get hot flashes.

Hot flashes between ages 60 and 65 are infrequent, but some individuals can have hot flashes often enough that they become bothersome.

If you’re still getting hot flashes or other symptoms of menopause at this age, talk with your doctor about hormone therapy and other treatments, as well as other possible conditions that could be causing those symptoms.

The transition to menopause begins and ends at different times. Factors like your family history, personal health history, and whether you smoke can all impact the timing.

If you think you’re in perimenopause or menopause, talk with a healthcare professional. A simple test can tell you for sure based on hormone levels in your blood.

Postmenopausal syndrome – PMC

1. Sherwin B. Menopause: Myths and realities. Psychological aspects of women’s health care. In: Stotland NL, Stewart DE, editors. The Interface Between Psychiatry and Obstetrics and Gynecology. Arlington: American Psychiatric Publishing; 2001. pp. 241–59. [Google Scholar]

2. Spinelli MG. Depression and hormone therapy. Clin Obstet Gynecol. 2004;47:428–36. [PubMed] [Google Scholar]

3. Adena MA, Gallagher HG. Cigarette smoking and the age at menopause. Ann Hum Biol. 1982;9:121–30. [PubMed] [Google Scholar]

4. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: Identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril. 1987;47:94–100. [PubMed] [Google Scholar]

5. Soares CN, Taylor V. Effects and management of the menopausal transition in women with depression and bipolar disorder. J Clin Psychiatry. 2007;68(Suppl 9):16–21. [PubMed] [Google Scholar]

6. Baram D. Physiology and symptoms of menopause. In: Steward DE, Robinson GE, editors. A Clinician’s Guide to Menopause. Health Press International: Washington DC; 1997. pp. 9–28. [Google Scholar]

7. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW) Fertil Steril. 2001;76:874–8. [PubMed] [Google Scholar]

8. Schiff I, Regestein Q, Tulchinsky D, Ryan KJ. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA. 1979;242:2405–4. [PubMed] [Google Scholar]

9. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril. 2001;75:1065–79. [PubMed] [Google Scholar]

10. Genant HK, Lucas J, Weiss S, Akin M, Emkey R, McNaney-Flint H, et al. Low-dose esterified estrogen therapy: Effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group. Arch Intern Med. 1997;157:2609–15. [PubMed] [Google Scholar]

11. Weiss SR, Ellman H, Dolker M. A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group. Obstet Gynecol. 1999;94:330–6. [PubMed] [Google Scholar]

12. Schiff I, Tulchinsky D, Cramer D, Ryan KJ. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA. 1980;244:1443–5. [PubMed] [Google Scholar]

13. Freedman RR, Woodward S, Sabharwal SC. Alpha 2-adrenergic mechanism in menopausal hot flushes. Obstet Gynecol. 1990;76:573–8. [PubMed] [Google Scholar]

14. Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol. 1987;156:561–5. [PubMed] [Google Scholar]

15. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. JAMA. 2003;289:2827–34. [PubMed] [Google Scholar]

16. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002;20:1578–83. [PubMed] [Google Scholar]

17. Suvanto-Luukkonen E, Koivunen R, Sundström H, Bloigu R, Karjalainen E, Häivä-Mällinen L, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: A prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause. 2005;12:18–26. [PubMed] [Google Scholar]

18. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet. 2000;356:2059–63. [PubMed] [Google Scholar]

19. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998;16:495–500. [PubMed] [Google Scholar]

20. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152:463–73. [PubMed] [Google Scholar]

21. Whiteman MK, Staropoli CA, Langenberg PW, McCarter RJ, Kjerulff KH, Flaws JA. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol. 2003;101:264–72. [PubMed] [Google Scholar]

22. Handa VL, Bachus KE, Johnston WW, Robboy SJ, Hammond CB. Vaginal administration of low-dose conjugated estrogens: Systemic absorption and effects on the endometrium. Obstet Gynecol. 1994;84:215–8. [PubMed] [Google Scholar]

23. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180:1072–9. [PubMed] [Google Scholar]

24. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T, et al. Postmenopausal hormones and incontinence: The Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol. 2001;97:116–20. [PubMed] [Google Scholar]

25. Cauley JA, Zmuda JM, Ensrud KE, Bauer DC, Ettinger B. Study of Osteoporotic Fractures Research Group. Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrinol Metab. 2001;86:5700–5. [PubMed] [Google Scholar]

26. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33. [PubMed] [Google Scholar]

27. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: A randomized controlled trial. JAMA. 2003;290:1042–8. [PubMed] [Google Scholar]

28. Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA. 2002;287:2668–76. [PubMed] [Google Scholar]

29. Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V, et al. Effects of ultralow-dose transdermal estradiol on bone mineral density: A randomized clinical trial. Obstet Gynecol. 2004;104:443–51. [PubMed] [Google Scholar]

30. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial. JAMA. 1998;280:2077–82. [PubMed] [Google Scholar]

31. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA. 1999;282:1344–52. [PubMed] [Google Scholar]

32. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282:637–45. [PubMed] [Google Scholar]

33. Soares CN. New York, Arlington, VA: American Psychiatric Publishing; 2004. Perimenopause-related Mood Disturbance: An Update on Risk Factors and Novel Treatment Strategies Available. In: Meeting Program and Abstracts. Psychopharmacology and Reproductive Transitions Symposium. American Psychiatric Association 157th Annual Meeting; May 1.6, 2004; pp. 51–61. [Google Scholar]

34. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61:62–70. [PubMed] [Google Scholar]

35. Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: A community based prospective study. Maturitas. 2002;42:195–200. [PubMed] [Google Scholar]

36. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: The Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63:385–90. [PubMed] [Google Scholar]

37. Steiner M, Dunn E, Born L. Hormones and mood: From menarche to menopause and beyond. J Affect Disord. 2003;74:67–83. [PubMed] [Google Scholar]

38. Halbreich U. Role of estrogen in postmenopausal depression. Neurology. 1997;48:16–9. [PubMed] [Google Scholar]

39. Huttner RP, Shepherd JE. Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women. Med Clin North Am. 2003;87:1065–76. [PubMed] [Google Scholar]

40. Sloan DM, Kornstein SG. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am. 2003;26:581–94. [PubMed] [Google Scholar]

41. Charney DA, Stewart DE. Psychiatric aspects. In: Steward DE, Robinson GE, editors. A Clinician’s Guide to Menopause. Health Press International: Washington DC; 1997. pp. 129–44. [Google Scholar]

42. Payne JL. The role of estrogen in mood disorders in women. Int Rev Psychiatry. 2003;15:280–90. [PubMed] [Google Scholar]

43. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol. 2003;158:347–56. [PubMed] [Google Scholar]

44. Dennerstein L, Lehert P, Burger H, Dudley E. Mood and the menopausal transition. J Nerv Ment Dis. 1999;187:685–91. [PubMed] [Google Scholar]

45. Rasgon NL, Dunkin J, Fairbanks L, Altshuler LL, Troung C, Elman S, et al. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study. J Psychiatr Res. 2007;41:338–43. [PubMed] [Google Scholar]

46. Genazzani AR, Gambacciani M, Simoncini T, Schneider HP. Hormone replacement therapy in climacteric and aging brain. International Menopause Society Expert Workshop, 15-18 March 2003, Pisa, Italy. Climacteric. 2003;6:188–203. [PubMed] [Google Scholar]

47. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry. 1979;36:550–4. [PubMed] [Google Scholar]

48. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–3. [PubMed] [Google Scholar]

49. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: A preliminary report. Am J Obstet Gynecol. 2000;183:414–20. [PubMed] [Google Scholar]

50. Schneider MA, Brotherton PL, Hailes J. The effect of exogenous oestrogens on depression in menopausal women. Med J Aust. 1977;2:162–3. [PubMed] [Google Scholar]

51. Schneider HP. Cross-national study of women’s use of hormone replacement therapy (HRT) in Europe. Int J Fertil Womens Med. 1997;42(Suppl 2):365–75. [PubMed] [Google Scholar]

52. Zweifel JE, O’Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology. 1997;22:189–212. [PubMed] [Google Scholar]

53. Amsterdam J, Garcia-España F, Fawcett J, Quitkin F, Reimherr F, Rosenbaum J, et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord. 1999;55:11–7. [PubMed] [Google Scholar]

54. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA. 2002;287:591–7. [PubMed] [Google Scholar]

55. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58:529–34. [PubMed] [Google Scholar]

56. Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, et al. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas. 2005;50:91–7. [PubMed] [Google Scholar]

57. Schiff R, Bulpitt CJ, Wesnes KA, Rajkumar C. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology. 2005;30:309–15. [PubMed] [Google Scholar]

58. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003;348:1839–54. [PubMed] [Google Scholar]

59. Heinrich AB, Wolf OT. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: A questionnaire study. Neuropsychobiology. 2005;52:17–23. [PubMed] [Google Scholar]

60. Robinson GE, Stirtzinger R. Psychoeducational programs and support groups at transition to menopause. In: Steward DE, Robinson GE, editors. A Clinician’s Guide to Menopause. Washington, DC: Health Press International; 1997. pp. 165–80. [Google Scholar]

61. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000;96:351–8. [PubMed] [Google Scholar]

62. La Rue A. New York: Plenum Press; 1992. Aging and Neuropsychological Assessment. [Google Scholar]

63. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345–57. [PubMed] [Google Scholar]

64. Duka T, Tasker R, McGowan JF. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology (Berl) 2000;149:129–39. [PubMed] [Google Scholar]

65. Caldwell BM, Watson RI. An evaluation of psychologic effects of sex hormone administration in aged women. I. Results of therapy after six months. J Gerontol. 1952;7:228–44. [PubMed] [Google Scholar]

66. Hackman BW, Galbraith D. Replacement therapy and piperazine oestrone sulphate (’Harmogen’) and its effect on memory. Curr Med Res Opin. 1976;4:303–6. [PubMed] [Google Scholar]

67. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia. JAMA. 1998;279:688–95. [PubMed] [Google Scholar]

68. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer’s Disease Cooperative Study. JAMA. 2000;283:1007–15. [PubMed] [Google Scholar]

69. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women’s Health Initiative Memory Study: A randomized controlled trial. JAMA. 2003;289:2651–62. [PubMed] [Google Scholar]

70. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study. JAMA. 2004;291:2959–68. [PubMed] [Google Scholar]

71. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med. 2002;11:367–77. [PubMed] [Google Scholar]

72. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, et al. Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril. 2002;77:660–5. [PubMed] [Google Scholar]

73. Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuroendocrinology. 1985;10:325–35. [PubMed] [Google Scholar]

74. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril. 2003;79:1341–52. [PubMed] [Google Scholar]

75. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682–8. [PubMed] [Google Scholar]

76. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, et al. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol. 2005;105:944–52. [PubMed] [Google Scholar]

77. Soares CN, Joffe H, Steiner M. Menopause and mood. Clin Obstet Gynecol. 2004;47:576–91. [PubMed] [Google Scholar]

78. Murphy PJ, Campbell SS. Sex hormones, sleep, and core body temperature in older postmenopausal women. Sleep. 2007;30:1788–94. [PMC free article] [PubMed] [Google Scholar]

79. Krystal AD. Depression and insomnia in women. Clin Cornerstone. 2004;6(Suppl 1B):S19–28. [PubMed] [Google Scholar]

80. Miller EH. Women and insomnia. Clin Cornerstone. 2004;6(Suppl 1B):S8–18. [PubMed] [Google Scholar]

81. Shin K, Shapiro C. Menopause, sex hormones, and sleep. Bipolar Disord. 2003;5:106–9. [PubMed] [Google Scholar]

82. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology. 2003;28(Suppl 2):17–54. [PubMed] [Google Scholar]

83. Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: Preliminary report. J Psychiatr Res. 2008;42:247–51. [PubMed] [Google Scholar]

84. Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord. 2004;6:2–13. [PubMed] [Google Scholar]

85. Claudia P, Andrea C, Chiara C, Stefano L, Giuseppe M, Vincenzo DL, et al. Panic disorder in menopause: A case control study. Maturitas. 2004;48:147–54. [PubMed] [Google Scholar]

86. Smoller JW, Pollack MH, Wassertheil-Smoller S, Barton B, Hendrix SL, Jackson RD, et al. Prevalence and correlates of panic attacks in postmenopausal women: Results from an ancillary study to the Women’s Health Initiative. Arch Intern Med. 2003;163:2041–50. [PubMed] [Google Scholar]

87. Lochner C, Hemmings SM, Kinnear CJ, Moolman-Smook JC, Corfield VA, Knowles JA. Corrigendum to gender in obsessive-compulsive disorder: Clinical and genetic findings. Eur Neuropsychopharmacol. 2004;14:437–45. [PubMed] [Google Scholar]

88. Bluming AZ. Hormone replacement therapy: Benefits and risks for the general postmenopausal female population and for women with a history of previously treated breast cancer. Semin Oncol. 1993;20:662–74. [PubMed] [Google Scholar]

89. Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol. 2001;185:S13–23. [PubMed] [Google Scholar]

90. Gorsky RD, Koplan JP, Peterson HB, Thacker SB. Relative risks and benefits of long-term estrogen replacement therapy: A decision analysis. Obstet Gynecol. 1994;83:161–6. [PubMed] [Google Scholar]

91. Col NF, Eckman MH, Karas RH, Pauker SG, Goldberg RJ, Ross EM, et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA. 1997;277:1140–7. [PubMed] [Google Scholar]

92. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med. 2001;344:276–85. [PubMed] [Google Scholar]

93. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet. 1997;350:1047–59. [PubMed] [Google Scholar]

94. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000;92:328–32. [PubMed] [Google Scholar]

95. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: A meta-analysis. Obstet Gynecol. 1995;85:304–13. [PubMed] [Google Scholar]

96. Syamala TS, Sivakami M. New Delhi: Benett Coleman and Co; 2007. India Women Reaching Menopause at 30: Study, in Times of India. [Google Scholar]

97. Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol. 1994;140:1091–5. [PubMed] [Google Scholar]

98. Chowta NK, Sebastian J, Chowta MN. Comparative study of menopausal symptoms in post menopausal and perimenopausal women. J Clin Diagn Res. 2008;2:959–62. [Google Scholar]

99. Taylor DL, Fonseka P. Symptom experience of Filipino American midlife women. Menopause. 1999;6:105–14. [PubMed] [Google Scholar]

100. Goonaratna C, Fonseka P, Wijeywardene K. Perimenopausal symptoms in Sri Lankan women. Ceylon Med J. 1999;44:63–9. [PubMed] [Google Scholar]

101. Lagos X, Navarro N, Illanes E, Bustos L. Prevalence of biological and psychological symptoms in perimenopausal women from different socioeconomic levels in the city of Temuco. Rev Med Chil. 1998;126:1189–94. [PubMed] [Google Scholar]

102. Schindler BA. The psychiatric disorders of midlife. Med Clin North Am. 1987;71:71–85. [PubMed] [Google Scholar]

103. Singh M, Singh G. A comparison of mental health status during menopause and post-menopause middle-aged working women. Internet J World Health Soc Politics. 2007;4:61–9. [Google Scholar]

104. Sagsöz N, Oguztürk O, Bayram M, Kamaci M. Anxiety and depression before and after the menopause. Arch Gynecol Obstet. 2001;264:199–202. [PubMed] [Google Scholar]

105. Prakash IJ, Murthy VN. Psychiatric morbidity and the menopause. Indian J Psychiatry. 1981;23:242–6. [PMC free article] [PubMed] [Google Scholar]

106. Indira SN, Murthy VN. Nature of psychiatric disturbances in menopausal women. Indian J Clin Psychol. 1980;7:7. [Google Scholar]

107. Nagar S, Dave P. Perception of women towards physiological problems faced at menopause. Anthropologist. 2005;7:173–5. [Google Scholar]

14 signs – harbingers of imminent menopause

Perimenopause – this is the name of this transitional period, when the reproductive function fades completely. This period can drag on for several years, pretty poisoning the life of a woman.

Menopause, also known as menopause, is a milestone in the life of every woman. It means that the reproductive phase of life is over. True, there are exceptions – even after the onset of menopause, a woman can still become pregnant, but this happens extremely rarely. And the so-called preparatory period precedes menopause – perimenopause.

What it is

Perimenopause begins a few years before menopause. The ovaries produce less and less estrogen and other hormones – more than 160 biologically active substances in total, the hormonal background changes. This usually happens after 40 years, but it also happens that ovarian function fades much earlier – about 30 years.

This transitional period lasts an average of 8-10 years, until the ovaries finally exhaust their resource – the ovarian reserve. It is laid genetically during prenatal development, and it cannot be influenced in any way.

And at the late stage of perimenopause, the amount of hormones produced by the ovaries drops to a minimum and they appear in a woman’s life – the symptoms of menopause. Officially, menopause occurs when 12 months have passed since the last menstruation. The active mechanism of aging starts.

Climax with acceleration

Menopause can come earlier than usual – this is influenced by many factors.

– The age of menopause is genetically programmed, but not only genetics is important.

Usually, a woman’s menopause occurs at about the same age at which he caught up with her mother and grandmother. However, there are other factors that provoke early menopause:

– Operations on the ovaries.

– Repeated unsuccessful IVF attempts with ovarian stimulation.

– Chemotherapy.

– Bad habits, in particular smoking.

Symptoms of perimenopause

There can be a lot of them, and they usually increase closer to the onset of menopause. Typical symptoms include the following:

Hot flashes – when waves of heat rush to the face, the heart beats faster, sweating increases;

– Soreness of the mammary glands;

– Premenstrual syndrome is more severe;

– Decreased sex drive;

– Constant fatigue;

– Irregular periods;

– Forgetfulness and difficulty concentrating;

– Pain in the muscles;

– Vaginal dryness, discomfort during sex;

– Leakage of urine when coughing or sneezing, frequent urination;

– Mood swings;

– Sleep problems.

Unfortunately, it is unlikely to completely remove these symptoms. But many can be stopped so that their impact on the quality of life is minimal. And one of the best ways to cope with them is physical activity. Which, by the way, also reduces the risk of osteoporosis, which after the onset of menopause becomes one of the main health problems.

“You should definitely visit a gynecologist: the doctor will conduct a gynecological examination, give a referral for a blood test for hormones and tumor markers. The main indicators of the approaching menopause are a reduced level of anti-Müllerian hormone and a high level of follicle-stimulating and luteinizing hormones. In addition, you will need to do an ultrasound of the pelvic organs, check the mammary glands and the condition of the cervix using colposcopy.

You can’t prescribe any medications on your own – doctors place a special emphasis on this. After all, only a doctor can choose the right means: someone will need vitamin complexes with phytoestrogens, and someone will need hormone replacement therapy.

What is menopause – menopause, symptoms of menopause.

Menopause or menopause is a natural period in a woman’s life, when the hormonal balance in the body changes, decreases, and then completely disappears the possibility of becoming pregnant, menstruation stops. The ovaries produce less sex hormones as a result of the aging process.

Menopause (menopause) is not a disease, but a physiological restructuring of the body. For some menopause goes unnoticed, while others have a number of complaints. It can last several years and consists of three stages.

Stages of menopause (menopause)

1. Perimenopause is a transitional period that begins, on average, 4 years before menopause (ages 45-47) and continues for 12 months after the cessation of menstruation. The first sign of perimenopause is changes in the menstrual cycle, both in duration and in the amount of blood loss. In the last one to two years of perimenopause, the fall in estrogen accelerates. At this stage, symptoms of menopause are observed. Women still have menstrual cycles and can become pregnant.
2. Menopause is the time of the last natural bleeding (menses). Begins either 12 months after the last menstrual period, or after the cessation of menstruation for a clinical reason.
3. Postmenopause – the period when a woman has not had bleeding within a year after menopause, which continues until 65-69 years, gradually passing into the period of reproductive aging.

Why does menopause occur?

Natural menopause occurs at the beginning of the age of 50, when it is not caused by surgery or other disease. But there are reasons that can provoke an artificial menopause.

• Natural reduction of reproductive hormones .

As a woman approaches her 40s, the ovaries begin to produce less estrogen and progesterone, the hormones that regulate menstruation, and fertility declines. Menstrual periods become longer or shorter, heavier or lighter, and more or less frequent. On average, by the age of 51, they stop.

• Primary ovarian failure.

About 1% of women experience menopause before the age of 40 (premature menopause). It may be the result of an inability of the ovaries to produce normal levels of reproductive hormones, which is due to genetic factors or autoimmune diseases (decreased immune defenses). Often, the cause of premature menopause cannot be found. Hormone therapy is usually recommended for these women, at least until the natural age of menopause, to protect the brain, heart, and bones.

• Surgery to remove the ovaries (oophorectomy).

Surgery causes immediate menopause. Periods stop and menopausal symptoms begin to appear. They can be serious because hormonal changes happen suddenly rather than gradually over several years.

• Surgery to remove the uterus (hysterectomy) ,

usually does not cause immediate menopause. Although menstruation has stopped, the ovaries still produce estrogen and progesterone.

• Chemotherapy and radiotherapy.

These cancer treatments may induce menopause and its symptoms during or shortly after treatment. The cessation of menstruation and fertility do not always occur. Radiation therapy affects the function of the ovaries only if the radiation is directed at them. Therapy of other parts of the body will not affect menopause.

Symptoms of menopause

According to statistics, approximately 30% of women experience menopausal disorders, another 30% – in an aggravated form. During menopause, various physical and mental changes occur.

Changes associated with perimenopause and menopause include:

• Lower fertility

As a woman approaches the end of the reproductive stage, but before the onset of menopause, estrogen levels begin to drop. This reduces the chances of getting pregnant.

• Irregular menses

The first sign of approaching menopause is less regular periods. They may come less often or more often, they may be heavier or lighter.

• Vaginal dryness and discomfort

Vaginal dryness, itching and discomfort may begin during perimenopause and continue into menopause. A woman with any of these symptoms may experience irritation and discomfort during intercourse. Various moisturizers, lubricants, and medications reduce vaginal dryness and related problems.

• Tides

Hot flashes often occur during menopause. They cause a sudden sensation of warmth in the upper body. The flush may start in the face, neck, or chest and progress up or down. The duration of each is up to 1-2 minutes. Various factors can provoke – climate change, stress.

• Psycho-emotional changes

Depression, anxiety and low mood are common during menopause. Often there are bouts of irritability and crying.

• Sleep disorders

During menopause, sleep disorders, constant feelings of weakness, decreased performance, memory and concentration may begin.

• Physical changes

Physical changes may develop during menopause, such as:

• weight gain;
• changes in color, texture and volume of hair;
• skin problems;
• reduction and pain in the chest;
• Urinary incontinence.

Complications

After menopause, the risk of certain diseases increases. Examples include:

Diseases of the heart and blood vessels (cardiovascular) . When estrogen levels decrease, the risk of cardiovascular disease increases. Heart disease is the leading cause of death for both women and men. Therefore, it is important to exercise regularly, eat a healthy diet and maintain a normal weight. Ask your doctor for advice on how to protect your heart, such as how to lower your cholesterol or blood pressure if it’s too high.

Osteoporosis. This condition causes bones to become brittle and weak, which increases the risk of fractures. During the first few years after menopause, bone density can be lost rapidly, increasing the risk of osteoporosis. Postmenopausal women with osteoporosis are particularly susceptible to fractures of the spine, hips, and wrists.

Urinary incontinence. The tissues of the vagina and urethra lose elasticity, resulting in a sudden and intense urge to urinate, which can develop into incontinence. Strengthening the pelvic floor muscles, with Kegel exercises and topical vaginal estrogen, can help relieve these symptoms. Hormone therapy is also an effective treatment option.

Sexual function. Vaginal dryness due to decreased moisture production and loss of elasticity may cause discomfort and slight bleeding during intercourse. In addition, decreased sensitivity affects sexual activity (libido). Vaginal moisturizers and water-based lubricants may help. If this is not enough, estrogen treatment available as a vaginal cream, tablet, or ring can be used.

Weight gain. Many women gain weight during and after menopause due to slower metabolism. In this case, you have to change your eating habits and exercise more to maintain your current weight.

How is menopause (menopause) diagnosed?

A gynecologist can diagnose menopause in several ways:

The first is a discussion of the menstrual cycle over the past year.

Another way is the FSH blood test, which checks the level of follicle stimulating hormone. FSH analysis is a regulator of the development of ovarian follicles in the female body. However, this test can be misleading at the onset of menopause when the body is in transition and hormone levels fluctuate up and down.

A hormone test should always be interpreted in the context of what is happening with the menstrual cycle.

Prevention of menopausal disorders

• Eat a healthy diet. Proper nutrition contributes greatly to a person’s overall health. During menopause, the diet should contain a variety of fruits, vegetables, and grains. Eliminate fatty, spicy, salty foods from your diet. Reduce the consumption of meat, sausages, smoked meats. Take supplements with calcium, vitamin D, supplements with Omega 3 polyunsaturated fatty acids every day (dosage will help you choose a doctor). Drink alcohol and caffeine in moderation. Do not smoke.
• Drinking plenty of water is important for menopausal women : experts recommend drinking about 1.5-2 liters per day. Water replenishes the fluid lost after excessive sweating during hot flashes and reduces their frequency.
• Exercise (at least half an hour a day), try to stay active, this will help reduce hot flashes and prevent osteoporosis.
• Do not wear synthetic fabrics . Synthetic fabrics impair heat transfer and impair ventilation, which contributes to overheating and an increase in the frequency of hot flashes. In addition, synthetic clothing absorbs moisture worse and accelerates the appearance of an unpleasant sweat odor. It is better to give preference to clothes made of cotton, linen or viscose. These recommendations also apply to bed linen.
• Don’t overexert yourself . Tension, stress, fatigue provoke the appearance of hot flashes, so a woman during menopause should not take on too many responsibilities. Do not try to do everything at once, alternate work with rest, pay attention to your health. A good night’s sleep is important, it significantly reduces stress levels and reduces the frequency of hot flashes.

Treatment of menopause (menopause)

Menopause is a natural process. Many symptoms disappear over time. But if they’re causing problems, treatment can help you feel better.

• Hormone replacement therapy (HRT). Taking hormone replacement drugs that are no longer produced in the body. Certain menopausal medications or combinations of them can help with hot flashes and vaginal symptoms, as well as strengthen bones. But they can also put you at risk for health problems like heart disease or breast cancer, so you should take the lowest dose that works for the shortest amount of time.
• Local hormonal therapy. This is an estrogen cream or gel that is inserted into the vagina to relieve dryness.
• Non-hormonal preparations. Includes drugs for depression, insomnia, blood pressure, and others.
• Medicines for osteoporosis. Vitamin D medications or supplements can be taken to keep bones strong.